Company Search:
Advanced Search
Sponsored Links
Erytech Pharma SA - ADR Company Snapshot
Erytech Pharma SA operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Erytech Pharma SA with three other companies in this sector in UNITED STATES : Avita Therapeutics Inc (2019 sales of $5.83 million of which 76% was Operating-Americas.), Translate Bio Inc ($7.80 million of which 100% was Biological products except diagnostic), and CASI Pharmaceuticals Inc ($4.13 million of which 100% was Innovative Therapeutics - Healthcare & S).

Sales Analysis. During the year ended December of 2019, sales at Erytech Pharma SA were $5.91 million. This is an increase of 12.7% versus 2018, when the company's sales were $5.24 million.
  Stock Performance Chart for Erytech Pharma SA - ADR
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 7.40
(Figures in U.S. Dollars)
1 Week 14.9%   13 Weeks -0.5%  
4 Weeks -18.9%   52 Weeks 40.1%  
Erytech Pharma SA - ADR Key Data:
  Ticker: ERYP Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 5,905,073
(Year Ending Jan 2020).
Employees: 172
  Currency: U.S. Dollars Market Cap: 132,856,751
  Fiscal Yr Ends: December Shares Outstanding: 17,953,615
  Share Type: Common Closely Held Shares: 463,759
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.